Chester County News and Community Website
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced that, globally, 250,000 patients have been treated with the UroLift® System, a proven, minimally invasive approach to treating benign prostatic hyperplasia (BPH).
Read MoreWASHINGTON, D.C. — This week, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) – the first drug for positron emission tomography (PET) imaging of prostate-specific …
Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) recently announced the expansion of its UroLift® System portfolio with the introduction of the UroLift® Advanced Tissue Control (ATC)™ System. The new system, which builds …
Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced that 200,000 patients have been treated with the minimally invasive UroLift® System for benign prostatic hyperplasia (BPH) worldwide.
Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced that data from three studies of the UroLift® System were presented at the European Association of Urology (EAU) 2020 virtual congress, underscoring the …
Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced results of a new survey showing that the majority of American men over age 40 are prescribed multiple medications to treat a …
Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced that the company will host a free community health talk to discuss the symptoms, diagnosis and treatment options for enlarged prostate, also …
Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced that data from two analyses of the UroLift® System were presented at the American Urological Association (AUA) 2020 Virtual Science event.
Read More